Moss 27.08.20

Vingulmork Predictor AS, a company controlled by Erling Sundrehagen, Chief Scientific Officer in Gentian Diagnostics AS (“Gentian”), has sold 40,000 shares at NOK 74 per share raising gross proceeds of NOK 2.96 million. The proceeds will be used to settle tax obligations from a real estate transaction in Sweden. After the Transaction, Erling Sundrehagen and associated companies own 184,083 shares and 50,000 options in Gentian. Erling Sundrehagen and associated companies have entered into a lock-up agreement for 6 months for the remaining shares they hold in Gentian.

The transaction was done as a block trade towards a large Norwegian institutional investor

This information is subject to the disclosure requirements set out in section 5-12 of the Norwegian Securities Trading Act.

For further information, please contact:

Njaal Kind
CFO, Gentian Diagnostics AS
E-mail: njaal.kind@gentian.no
Cell Phone: +47 919 06 525